• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

粒细胞集落刺激因子给药的最佳时机以实现有效的自体干细胞采集。

Optimal timing of G-CSF administration for effective autologous stem cell collection.

机构信息

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

出版信息

Bone Marrow Transplant. 2011 Jun;46(6):806-12. doi: 10.1038/bmt.2010.194. Epub 2010 Aug 9.

DOI:10.1038/bmt.2010.194
PMID:20697366
Abstract

The best time of G-CSF administration for PBPC collection remains to be defined. We aimed to identify optimal G-CSF administration timing for efficient autologous stem cell collection. A total of 262 lymphoma or multiple myeloma patients, who underwent PBPC collection from January 2000 to March 2008, were included. PBPCs were mobilized with chemotherapy followed by lenograstim at 10 μg/kg/day. Patients received lenograstim at 2000 hours, about half a day before leukapheresis (PM group) before November 2004, and at 0600 hours, 3 h before apheresis (AM group) subsequently. In the AM group, the median number of total collected CD34+ cells/kg was greater over a shorter duration of apheresis, and the median number of collected CD34+ cells/kg at first leukapheresis was larger. Stem cell collection efficacy (ratio of total collected CD34+ cells/kg per number of leukapheresis procedures) was higher, and proportion of patients who yielded an optimum harvest was larger. The statistically significant between-group difference was observed only in patients with high-dose CY chemotherapy for stem cell mobilization in subgroup analysis. The present study showed that G-CSF injection 3 h before apheresis improved the efficacy of autologous stem cell collection.

摘要

粒细胞集落刺激因子(G-CSF)给药用于外周血造血干细胞(PBPC)采集的最佳时间仍有待确定。本研究旨在确定最佳的 G-CSF 给药时间,以实现高效的自体干细胞采集。

2000 年 1 月至 2008 年 3 月期间,共纳入 262 例淋巴瘤或多发性骨髓瘤患者进行 PBPC 采集。采用化疗联合粒细胞集落刺激因子(10μg/kg/d)进行 PBPC 动员。患者于 2000 时(PM 组),即白细胞单采前约半天,或 0600 时(AM 组),即白细胞单采前 3h 接受粒细胞集落刺激因子治疗。在 AM 组,在更短的白细胞单采时间内,总采集的 CD34+细胞/kg 中位数更多,首次白细胞单采的 CD34+细胞/kg 中位数更大。干细胞采集效率(每例白细胞单采次数的总采集 CD34+细胞/kg 比值)更高,产生最佳采集效果的患者比例更大。仅在亚组分析中,对于接受高剂量环磷酰胺(CY)化疗进行干细胞动员的患者,组间存在统计学显著差异。本研究表明,白细胞单采前 3h 给予 G-CSF 可提高自体干细胞采集的效果。

相似文献

1
Optimal timing of G-CSF administration for effective autologous stem cell collection.粒细胞集落刺激因子给药的最佳时机以实现有效的自体干细胞采集。
Bone Marrow Transplant. 2011 Jun;46(6):806-12. doi: 10.1038/bmt.2010.194. Epub 2010 Aug 9.
2
[Optimization of mobilization regimes of blood hemopoietic stem cells in patients with multiple myeloma].[多发性骨髓瘤患者造血干细胞动员方案的优化]
Ter Arkh. 2011;83(7):50-7.
3
Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.粒细胞集落刺激因子与粒细胞巨噬细胞集落刺激因子联合强化化疗用于多发性骨髓瘤外周血干细胞动员和自体移植的随机对照研究
Biol Blood Marrow Transplant. 2004 Jun;10(6):395-404. doi: 10.1016/j.bbmt.2004.02.001.
4
Mobilization strategies for the collection of peripheral blood progenitor cells: Results from a pilot study of delayed addition G-CSF following chemotherapy and review of the literature.外周血祖细胞采集的动员策略:化疗后延迟添加粒细胞集落刺激因子的一项初步研究结果及文献综述
Exp Hematol. 2006 Nov;34(11):1443-50. doi: 10.1016/j.exphem.2006.06.022.
5
CD34+ dose-driven administration of granulocyte colony-stimulating factor after high-dose chemotherapy in lymphoma patients.淋巴瘤患者大剂量化疗后CD34+细胞剂量驱动的粒细胞集落刺激因子给药
Eur J Haematol. 2007 Feb;78(2):111-6. doi: 10.1111/j.1600-0609.2006.00793.x.
6
Peripheral blood progenitor cell collection without close monitoring of peripheral blood CD34+ cells: A feasible strategy for multiple myeloma or pre-treated Non-Hodgkin's Lymphoma patients mobilized with low-dose cyclophosphamide plus G-CSF.在不密切监测外周血CD34+细胞的情况下进行外周血祖细胞采集:一种适用于接受低剂量环磷酰胺加粒细胞集落刺激因子动员的多发性骨髓瘤或预处理非霍奇金淋巴瘤患者的可行策略。
Transfus Apher Sci. 2009 Apr;40(2):91-5. doi: 10.1016/j.transci.2009.01.015. Epub 2009 Feb 23.
7
Blood stem cell collection using chemotherapy with or without systematic G-CSF: experience in 52 patients with multiple myeloma.使用化疗联合或不联合系统性粒细胞集落刺激因子(G-CSF)进行造血干细胞采集:52例多发性骨髓瘤患者的经验
Bone Marrow Transplant. 1999 Sep;24(5):463-6. doi: 10.1038/sj.bmt.1701910.
8
Blood progenitor cell (BPC) mobilization studied in multiple myeloma, solid tumor and non-Hodgkin's lymphoma patients after combination chemotherapy and G-CSF.在多发性骨髓瘤、实体瘤和非霍奇金淋巴瘤患者接受联合化疗和粒细胞集落刺激因子(G-CSF)后,对血液祖细胞(BPC)动员情况进行了研究。
Bone Marrow Transplant. 1997 Mar;19(6):529-37. doi: 10.1038/sj.bmt.1700705.
9
Predicting hematopoietic stem cell mobilization failure in patients with multiple myeloma: a simple method using day 1 CD34+ cell yield.预测多发性骨髓瘤患者造血干细胞动员失败:一种利用第1天CD34+细胞产量的简单方法。
J Clin Apher. 2011;26(3):111-5. doi: 10.1002/jca.20278. Epub 2011 Jan 6.
10
Peripheral blood hematopoietic stem cell mobilization and collection efficacy is not an independent prognostic factor for autologous stem cell transplantation.外周血造血干细胞动员及采集效果并非自体干细胞移植的独立预后因素。
Transfusion. 2007 Dec;47(12):2207-16. doi: 10.1111/j.1537-2995.2007.01448.x. Epub 2007 Aug 21.

引用本文的文献

1
Peripheral Blood Monocyte Count is a Predictor of Successful Peripheral Blood Stem Cell Harvest After Chemo-Mobilization in Patients with Malignant Lymphoma.外周血单核细胞计数是恶性淋巴瘤患者化疗动员后外周血干细胞采集成功的预测指标。
Indian J Hematol Blood Transfus. 2018 Apr;34(2):347-349. doi: 10.1007/s12288-017-0848-2. Epub 2017 Jul 7.
2
Optimizing Stem Cells Mobilization Strategies to Ameliorate Patient Outcomes: A Review of Guide- lines and Recommendations.优化干细胞动员策略以改善患者预后:指南与建议综述
Int J Hematol Oncol Stem Cell Res. 2017 Jan 1;11(1):78-88.
3
Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation.
多发性骨髓瘤和淋巴瘤患者的自体造血干细胞动员:欧洲血液与骨髓移植组的立场声明
Bone Marrow Transplant. 2014 Jul;49(7):865-72. doi: 10.1038/bmt.2014.39. Epub 2014 Mar 31.
4
Efficacy of stem cell mobilization in patients with newly diagnosed multiple myeloma after a CTD (cyclophosphamide, thalidomide, and dexamethasone) regimen.新诊断多发性骨髓瘤患者在 CTD(环磷酰胺、沙利度胺和地塞米松)方案后进行干细胞动员的疗效。
Int J Hematol. 2013 Jan;97(1):92-7. doi: 10.1007/s12185-012-1237-0. Epub 2012 Dec 12.
5
Lenograstim: a review of its use in chemotherapy-induced neutropenia, for acceleration of neutrophil recovery following haematopoietic stem cell transplantation and in peripheral blood stem cell mobilization.粒细胞集落刺激因子:在化疗引起的中性粒细胞减少症中的应用评价,用于加速造血干细胞移植后中性粒细胞的恢复和外周血造血干细胞的动员。
Drugs. 2011 Apr 16;71(6):679-707. doi: 10.2165/11206870-000000000-00000.